🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research trial studies the development of a blood test for detecting a...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-07
Trial ID
NCT00806650
RATIONALE: Determination of genetic markers for colorectal cancer may impro...
Status
Completed
Location
CCOP - Mayo Clinic Scottsdale Oncology Program
Start Date
1997-09
Trial ID
NCT00014079
Treatments Being Tested
This study aims to understand how differences in the NOTCH2NLC gene affect ...
Status
Recruiting
Location
Qingyang District
Start Date
2026-04-01
Trial ID
NCT07670169
Treatments Being Tested
The GCAIO study is an innovative, multimodal research initiative designed t...
Status
Recruiting
Location
University Hospital Bonn
Start Date
2023-09-01
Trial ID
NCT06460142
Treatments Being Tested
RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-09
Trial ID
NCT00673569
GENCONCOR-2 is a translational research aimed to compare the molecular prof...
Status
Recruiting
Location
Blokhin's Russian Cancer Research Center
Start Date
2026-04-01
Trial ID
NCT07464470
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth...
Status
Terminated
Location
Universitair Ziekenhuis Antwerpen
Start Date
2008-02
Trial ID
NCT00646659
Treatments Being Tested
To distinguish various molecular subtypes of gliomas by spectra data obtain...
Status
Unknown
Location
Beijing Tiantan Hospital
Start Date
2022-12-01
Trial ID
NCT06363162
Treatments Being Tested
The investigators wish to document the distribution of EGFR somatic mutatio...
Status
Unknown
Location
Royal Marsden
Start Date
2013-09
Trial ID
NCT01838577
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
City of Hope Medical Center
Start Date
2011-10-03
Trial ID
NCT01267812